SCHEMBL3633068

SCHEMBL3633068

N#Cc1ccc(C(=O)N2CCCCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.71
ALDH1A1 P00352 4/20 0.71
EPHX2 P34913 1/20 0.60
PDK1 Q15118 1/20 0.57
PDK2 Q15119 1/20 0.57
PDK3 Q15120 1/20 0.57
PDK4 Q16654 1/20 0.57
MKNK1 Q9BUB5 1/20 0.56
MKNK2 Q9HBH9 1/20 0.56
SLC6A7 Q99884 1/20 0.56
MEN1 O00255 1/20 0.56
TSHR P16473 1/20 0.56
KMT2A Q03164 1/20 0.56
MAPK1 P28482 1/20 0.54
CA12 O43570 2/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA7 P43166 2/20 0.54
CA9 Q16790 2/20 0.54
CA14 Q9ULX7 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31387924 0.98 HPGD (0.68) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL31387922 0.98 HPGD (0.68) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL2677750 0.87 PDK1 (0.56) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL7132525 0.84 HPGD (1.00) HPGDALDH1A1MEN1TSHRKMT2A
SCHEMBL27479149 0.84 HPGD (1.00) HPGDALDH1A1MEN1TSHRKMT2A
SCHEMBL1376624 0.84 PDK1 (0.59) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL1375337 0.84 SIGMAR1 (0.64) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL2002543 0.84 ALDH1A1 (0.56) HPGDALDH1A1EPHX2PDK1PDK2
SCHEMBL13504026 0.83 GRM5 (0.68) HPGDALDH1A1PDK1PDK2PDK3
SCHEMBL21524887 0.83 PHGDH (0.63) HPGDALDH1A1PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177416-A1 PREPARING METHOD OF COMPOUNDS INCLUDING AMIDE GROUP FROM TERTIARY AMINE Research & Business Foundation Sungkyunkwan University (KR) 2022-06-09 US disclosed
WO-2021121420-A1 BENZOPYRAZOLE COMPOUND AND INTERMEDIATE, PREPARATION METHOD, AND APPLICATION THEREOF 江苏凯迪恩医药科技有限公司 2021-06-24 WO disclosed
CN-101790520-A Method for preparing halogenated amines WYETH CORP 2010-07-28 CN disclosed
EP-2144890-A1 METHOD FOR PREPARING HALOGENATED AMINES Wyeth (US) 2010-01-20 EP disclosed
WO-2008098103-A1 METHOD FOR PREPARING HALOGENATED AMINES WYETH (US) 2008-08-14 WO disclosed
US-20080188659-A1 Method for Preparing Halogenated Amines WYETH (US) 2008-08-07 US disclosed
US-20080188659-A1 Method for Preparing Halogenated Amines WYETH (US) 2008-08-07 US disclosed
US-20080188659-A1 Method for Preparing Halogenated Amines WYETH (US) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188659-A1 Method for Preparing Halogenated Amines PNMT, ABL1, INMT HPGD 2980/4885ALDH1A1 1194/4885EPHX2 711/4885
US-20220177416-A1 PREPARING METHOD OF COMPOUNDS INCLUDING AMIDE GROUP FROM TERTIARY AMINE TYR, NAT1, SAT1 HPGD 3544/4885ALDH1A1 2021/4885EPHX2 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.